MedGene Therapeutics, Inc.
No bio yet
This person is not in the org chart
This person is not in any teams
This person is not in any offices
MedGene Therapeutics, Inc.
MedGene Therapeutics is focused on developing ACT treatments (PMBC derived tumor-reactive T cells-Natural Unmodified CD8+ lymphocytes) for two cancers—MSTS (metastatic soft tissue sarcoma) and MFTC (metastatic follicular thyroid cancer)—using NIH patented technology with Worldwide Exclusive License Agreement of commercialization.